Effect of an AI-Supported Chatbot on Nursing Students' Clinical Decision-Making in Gynecological Oncology

September 4, 2026 updated by: Ahsen Demirhan, Sakarya University

The Effect of an Artificial Intelligence-Supported Educational Chatbot on Nursing Students' Knowledge of Gynecologic Cancers and Clinical Decision-Making Skills: A Randomized Controlled Trial

This randomized controlled trial aims to determine the effect of an artificial intelligence (AI)-supported educational chatbot (OSCE Coach Platform) on nursing students' knowledge of gynecologic cancers and their self-reported clinical decision-making skills. Third-year undergraduate nursing students will be randomized into either an intervention group, utilizing the AI-supported chatbot, or a control group, receiving conventional education. Both groups will be assessed before and after the intervention.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

110

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Turkey
      • Sakarya, Turkey, Turkey (Türkiye), 54050
        • Sakarya University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Enrolled as a third-year undergraduate nursing student.
  • Successfully completed the Obstetrics and Gynecology Nursing (Women's Health and Diseases Nursing) course.
  • Volunteered to participate and provided digital informed consent.

Exclusion Criteria:

- No additional exclusion criteria.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: AI-Supported Chatbot Group
Participants in this group access the web-based OSCE Coach platform. They complete five sequential AI-supported virtual patient scenarios focusing on cervical, endometrial, ovarian, vulvar, and vaginal cancers. The system provides mastery-based progression and immediate individualized feedback using a predefined five-domain rubric.
Other: AI-Supported OSCE Coach Platform
A custom web-based educational platform combining AI-supported virtual patient interaction with standardized case scenarios, predefined clinical tasks, and immediate rubric-based feedback.
No Intervention: Conventional Education Group
Participants in this group continue their standard Women's Health and Diseases Nursing course. They complete a standard virtual patient assessment without receiving access to the AI-supported training scenarios, individualized feedback, or mastery-based practice.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Clinical Decision Making in Nursing Scale-Turkish Version (CDMNS-Tr) Score
Time Frame: Baseline (Day 1, before the assigned study procedures) and immediately after completion of the assigned study procedures on Day 1.
The CDMNS-Tr is a 40-item scale assessing self-reported clinical decision-making. Items are rated on a 5-point Likert scale ranging from 1 (never) to 5 (always), with eighteen negatively worded items being reverse-scored. Total scores range from 40 to 200, with higher scores indicating a higher self-perception of clinical decision-making abilities.
Baseline (Day 1, before the assigned study procedures) and immediately after completion of the assigned study procedures on Day 1.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Gynecological Oncology Knowledge Test Score
Time Frame: Baseline (Day 1, before the assigned study procedures) and immediately after completion of the assigned study procedures on Day 1.
A 15-item multiple-choice test developed to evaluate cognitive learning outcomes regarding gynecological oncology and nursing care. Each correct answer is awarded 1 point, while incorrect or blank answers receive 0 points. Total scores range from 0 to 15, with higher scores indicating a higher level of knowledge.
Baseline (Day 1, before the assigned study procedures) and immediately after completion of the assigned study procedures on Day 1.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sakarya University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 20, 2026

Primary Completion (Actual)

July 10, 2026

Study Completion (Actual)

September 1, 2026

Study Registration Dates

First Submitted

September 2, 2026

First Submitted That Met QC Criteria

September 4, 2026

First Posted (Actual)

September 8, 2026

Study Record Updates

Last Update Posted (Actual)

September 10, 2026

Last Update Submitted That Met QC Criteria

September 4, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 02.09.2026

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe